Clinical trial

iDAP Injection in the Treatment of Parkinson's Disease

NCT06583291

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2024-10-01

PhaseEARLY_PHASE1

Study timeline

Study start (estimated)2024-10-01Date precision: day

Registry last updated2024-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

Allogeneic dopaminergic neural precursor cell(iDAP)DRUG

Sponsors & collaborators

Anhui Provincial Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06583291 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.